Preparation process and transdermal absorption of fusidic acid film

Published on Jan. 04, 2025Total Views: 515 times Total Downloads: 81 times Download Mobile

Author: CHEN Hui ¹ CAI Li ¹ NING Lin ^1, ²  LUO Chunmei ¹

Affiliation: 1. Department of Medical Imaging, School of Healthcare Technology, Chengdu Neusoft University, Chengdu 611844, China 2. Department of Pharmacy, School of Medicine, Electronic Science and Technology University, Chengdu 610054, China

Keywords: Fusidic acid film Preparation process Response surface methodology Transdermal absorption High-performance liquid chromatography

DOI: 10.12173/j.issn.2097-4922.202404185

Reference: CHEN Hui, CAI Li, NING Lin, LUO Chunmei.Preparation process and transdermal absorption of fusidic acid film[J].Yaoxue QianYan Zazhi,2024, 28(4):566-573.DOI: 10.12173/j.issn.2097-4922.202404185.[Article in Chinese]  Copied

Abstract
Full-text
References

Abstract

Objective To optimize the prescription of fusidic acid film and study its transdermal absorption behavior.

Methods The fusidic acid film was evaluated comprehensively based on the film-forming time, toughness, peelability, and viscosity. On the basis of single-factor experiments, response surface design experiments were used to optimize the prescription. HPLC was used for quality control of the fusidic acid film. The improved Franz diffusion cell apparatus was used to study the transdermal absorption behavior of the fusidic acid film.

Results The response surface design experiments yielded a prescription with good properties, consisting of 4.8% polyvinyl butyral, 1.9% hydroxypropyl methylcellulose MF, 2.0% triethyl citrate and 89.3% anhydrous ethanol. The 24-hour cumulative permeation rate was 87.74%, which was significantly better than that of commercially available fusidic acid cream.

Conclusion This experiment identified the optimal ratio and dosage of the prescription for fusidic acid film. The new formulation is of stable and controllable quality, providing a basis for the clinical use of fusidic acid film.

Full-text

Please download the PDF version to read the full text: download

References

1.冯娜. 夫西地酸乳膏在常见皮肤病中的应用[J]. 医学信息, 2019, 32(4): 63-65. [Feng N. Application of fusidic acid cream in common skin diseases[J]. Medical Information, 2019, 32(4): 63-65.] DOI: 10.3969/j.issn.1006-1959.2019.04.022.

2.Jyoti K, Malik G, Chaudhary M, et al. Chitosan and phospholipid assisted topical fusidic acid drug delivery in burn wound: Strategies to conquer pharmaceutical and clinical challenges, opportunities and future panorama[J]. Int J Biol Macromol, 2020, 161: 325-335. DOI: 10.1016/j.ijbiomac.2020.05.230.

3.宗时宇, 刘洋, 王春柳, 等. 透皮贴剂在中药研究中的应用及发展现状[J]. 中国药师, 2022, 25(3): 510-514. [Zong SY, Liu Y, Wang CL, et al. Application and development of transdermal patches in the studies of traditional Chinese medicine[J]. China Pharmacist, 2022, 25(3): 510-514.] DOI: 10.19962/j.cnki.issn1008-049X.2022.03.025.

4.屈思元, 刘立, 关鑫磊, 等. 基于FAERS数据库的两种剂型卡巴拉汀风险信号数据挖掘与比较[J]. 药物流行病学杂志, 2022, 31(7): 463-468. [Qu SY, Liu L, Guan XL, et al. Data mining and comparation on adverse drug events sign of two forms of rivastigmine based on FAERS Database[J]. Chinese Journal of Pharmacoepidemiology, 2022, 31(7): 463-468.] DOI: 10.19960/j.cnki.issn1005-0698.2022.07.006.

5.马晓辉. 中药透皮给药系统的研究进展[J]. 中国实用医药, 2015, 10(2): 246-248. [Ma XH. Research progress on transdermal drug delivery system of Traditional Chinese Medicine[J]. China Practical Medical, 2015, 10(2): 246-248.] DOI: 10.14163/j.cnki.11-5547/r.2015.02.180.

6.中国药典2020年版. 四部[S]. 2020: 21.

7.杨波, 纪宏宇, 车丽丽, 等. 复方延胡索涂膜剂成膜材料的优选[J]. 中国药师, 2017, 20(3): 469-472. [Yang B, Ji HY, Che LL, et al. Optimization of film-forming materials for compound rhizoma corydalis plastics[J]. China Pharmacist, 2017, 20(3): 469-472.] DOI: 10.3969/j.issn.1008-049X.2017.03.020.

8.潘晓鹃, 沈立, 徐超群, 等. 几种水溶液型涂膜剂成膜材料的性质研究及筛选[J]. 中国医院药学杂志, 2009, 29(12): 973-976. [Pan XJ, Shen L, Xu CQ, et al. Evaluation and screening of water-soluble pellicular materials for pellicles[J]. Chinese Journal of Hospital Pharmacy, 2009, 29(12): 973-976.] DOI: 10.3321/j.issn:1001-5213.2009.12.003.

9.苏海萍, 韩越, 马艳. 涂膜剂的研究进展[J]. 中国医院用药评价与分析, 2016, 16(1): 259. [Su HP, Han Y, Ma Y. Research progress on coating agents[J]. Evaluation and Analysis of Drug-Use in Hospitals of China, 2016, 16(1): 259.] DOI: 10.14009/j.issn.1672-2124.2016.s1.230.

10.程弘夏, 雷晓璐, 王仲, 等. 正交设计法优化黄柏涂膜剂成膜材料的制备工艺[J]. 化学与生物工程, 2012, 29(8): 63-65. [Cheng HX, Lei XL, Wang Z, et al. Optimization on preparation process of film-former for cortex phellodendri film by orthogonal experiment[J]. Chemistry& Bioengineering, 2012, 29(8): 63-65.] DOI: 10.3969/j.issn.1672-5425.2012.08.016.

11.周密, 徐晓勇, 马凤森, 等. 雷公藤涂膜剂的制备及其体外透皮试验[J]. 中成药, 2015, 37(3): 526-529. [Zhou M, Xu XY, Ma FS, et al. Preparation and in vitro transdermal behavior of tripterygium wilfordii Hook fextract pellicle[J]. Chinese Traditional Patent Medicine, 2015, 37(3): 526-529.] DOI: 10.3969/j.Issn.1001-1528. 2015.03.014.

12.Frederiksen K, Guy RH, Petersson K. The potential of polymeric film-forming systems as sustained delivery platforms for topical drugs[J]. Expert Opin Drug Deliv, 2016, 13(3): 349-360. DOI: 10.1517/17425247.2016.1124412.

13.陈念芬, 王延东, 陈茂玲. 高效液相色谱法测定夫西地酸眼用乳剂的含量[J]. 中国医药导报, 2009, 6(22): 72-73. [Chen NF, Wang YD, Chen ML. Determination of fusidic acid ophthalmic emulsion by HPLC[J]. China Medical Herald, 2009, 6(22): 72-73.] DOI: 10.3969/j.issn.1673-7210.2009.22.039.